You are here: Home » News-CM » Companies » News
Business Standard

Alembic Pharmaceuticals gets USFDA tentative approval for ANDA Ticagrelor Tablets, 90 mg

Capital Market 

has received tentative approval from the (USFDA) for its Application (ANDA) Tablets, 90 mg.

The tentatively approved ANDA is therapeutically equivalent to the reference listed (RLD), Brilinta Tablets, 90 mg, of Pharmaceuticals LP. tablets are indicated to reduce the rate of cardiovascular death, myocardial infarction, and in patients with acute coronary syndrome (ACS) or a history of (Ml).

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, July 12 2018. 11:08 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU